Pajič T, Lamovšek N, Fink M, Zupan Preložnik I, Černelč P. Bcr-aBL1 kinase domain mutation analysis in chronic myeloid leukaemia patients with suboptimal response to tyrosine kinase inhibitors. TEST ZdravVestn [Internet]. 1Dec.2012 [cited 5Aug.2024];81(SUPL II). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/755